Reference Hub: Prognosis and treatment of Tysabri-related Progressive Multifocal Leukoencephalopathy

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

In-depth resource

Prognosis and treatment of Tysabri-related Progressive Multifocal Leukoencephalopathy Resource Guide

In-depth context and analysis on this topic for researchers and advocates.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.

National Institutes of Health (NIH)

Reference: National Institutes of Health (NIH)

Authoritative source for clinical, regulatory, and public-health background reading.